<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://s1.daumcdn.net/pimg/whsnake/css/atom.css?ver=1.0" type="text/css"?>
<feed xmlns="http://www.w3.org/2005/Atom" version="1.0" >
  <title>MIDBAND</title>
  <link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412"/>
  <link rel="self" type="application/atom+xml" href="http://blog.daum.net/xml/atom/teddy8412"/>
  <rights>Europos Korea</rights>
  <author>
    <name><![CDATA[Europos Korea]]></name>
    <uri><![CDATA[http://blog.daum.net/teddy8412]]></uri>
  </author>
  <generator uri="http://blog.daum.net" version="1.0">Daum blog (blogmaster@daum.net)</generator>
  <id><![CDATA[tag:blog.daum.net,2013:teddy8412]]></id>
  <updated><![CDATA[2013-02-08T14:58:07Z]]></updated>
		  				<entry>
		    <title>MID MIDBAND Allergan plans to sell Lap-Band biz by midyear</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/249"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.249]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2013-02-08T14:58:07Z]]></updated>
		    <published><![CDATA[2013-02-08T14:58:07Z]]></published>
		    <content type="html">
		    	&lt;p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;

&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;background: white; margin: 12pt 0cm; text-align: left; word-break: keep-all; mso-pagination: widow-orphan; mso-outline-level: 3;&quot;  align=&quot;left&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: rgb(255, 102, 0); font-family: Verdana; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;Today's Top News&lt;/span&gt;&lt;/b&gt;&lt;b&gt;&lt;span style=&quot;color: black; font-family: Calibri; font-size: 18pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;

&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;background: white; margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;a name=&quot;1&quot;&gt;&lt;/a&gt;&lt;a name=&quot;N1000B&quot;&gt;&lt;/a&gt;&lt;b&gt;&lt;span style=&quot;color: rgb(51, 51, 51); font-family: Georgia; font-size: 14pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;1.&lt;/span&gt;&lt;/b&gt;&lt;a name=&quot;fiercemedicaldevices_com__wxVfREAHI6SVQ4&quot;&gt;&lt;/a&gt;&lt;span style=&quot;color: black; font-family: Georgia; font-size: 14pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림; mso-ansi-language: FR-BE;&quot; lang=&quot;FR-BE&quot;&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=186&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;b&gt;&lt;span style=&quot;color: black; mso-ansi-language: EN-US;&quot; &gt;&lt;u&gt;Allergan
plans to sell Lap-Band biz by midyear&lt;/u&gt;&lt;/span&gt;&lt;/b&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;color: black; font-family: Georgia; font-size: 14pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;

&lt;/font&gt;&lt;/p&gt;&lt;table style=&quot;mso-cellspacing: 0cm; mso-padding-alt: 0cm 0cm 0cm 0cm;&quot; Table&quot; border=&quot;0&quot; cellSpacing=&quot;0&quot; cellPadding=&quot;0&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
 &lt;/font&gt;&lt;tbody&gt;&lt;tr style=&quot;mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;td style=&quot;padding: 0cm; border: rgb(0, 0, 0); width: 23.25pt; background-color: transparent;&quot; width=&quot;31&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;td style=&quot;padding: 0cm; border: rgb(0, 0, 0); width: 112.5pt; background-color: transparent;&quot; vAlign=&quot;bottom&quot; width=&quot;150&quot;&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;color: rgb(136, 136, 136); font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;By Damian
  Garde&lt;/span&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;/span&gt;&lt;/p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;/td&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;td style=&quot;padding: 0cm; border: rgb(0, 0, 0); background-color: transparent;&quot; vAlign=&quot;bottom&quot;&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;span style=&quot;text-decoration: none; text-underline: none;&quot;&gt;&lt;v:shapetype id=&quot;_x0000_t75&quot; stroked=&quot;f&quot; filled=&quot;f&quot; path=&quot;m@4@5l@4@11@9@11@9@5xe&quot; o:preferrelative=&quot;t&quot; o:spt=&quot;75&quot; coordsize=&quot;21600,21600&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;
   &lt;v:stroke joinstyle=&quot;miter&quot;&gt;
   &lt;v:formulas&gt;
    &lt;v:f eqn=&quot;if lineDrawn pixelLineWidth 0&quot;&gt;
    &lt;v:f eqn=&quot;sum @0 1 0&quot;&gt;
    &lt;v:f eqn=&quot;sum 0 0 @1&quot;&gt;
    &lt;v:f eqn=&quot;prod @2 1 2&quot;&gt;
    &lt;v:f eqn=&quot;prod @3 21600 pixelWidth&quot;&gt;
    &lt;v:f eqn=&quot;prod @3 21600 pixelHeight&quot;&gt;
    &lt;v:f eqn=&quot;sum @0 0 1&quot;&gt;
    &lt;v:f eqn=&quot;prod @6 1 2&quot;&gt;
    &lt;v:f eqn=&quot;prod @7 21600 pixelWidth&quot;&gt;
    &lt;v:f eqn=&quot;sum @8 21600 0&quot;&gt;
    &lt;v:f eqn=&quot;prod @7 21600 pixelHeight&quot;&gt;
    &lt;v:f eqn=&quot;sum @10 21600 0&quot;&gt;
   &lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:f&gt;&lt;/v:formulas&gt;
   &lt;v:path o:connecttype=&quot;rect&quot; gradientshapeok=&quot;t&quot; o:extrusionok=&quot;f&quot;&gt;
   &lt;o:lock aspectratio=&quot;t&quot; v:ext=&quot;edit&quot;&gt;
  &lt;/o:lock&gt;&lt;/v:path&gt;&lt;/v:stroke&gt;&lt;/font&gt;&lt;/u&gt;&lt;/v:shapetype&gt;&lt;v:shape style=&quot;width: 6.75pt; height: 8.25pt;&quot; id=&quot;_x0000_i1025&quot; type=&quot;#_x0000_t75&quot; alt=&quot;http://assets.fiercemarkets.net/public/icons/comment_ico.gif&quot;&gt;&lt;/v:shape&gt;Bloomberg 6 Jan 2013&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;/td&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
 &lt;/font&gt;&lt;/tr&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
&lt;/font&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;

&lt;/font&gt;&lt;/p&gt;&lt;p style=&quot;background: white; margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;color: black; font-family: Georgia; font-size: 12pt; display: none; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림; mso-ansi-language: FR-BE; mso-hide: all;&quot; lang=&quot;FR-BE&quot;&gt;&amp;nbsp;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;

&lt;/font&gt;&lt;/p&gt;&lt;table style=&quot;mso-cellspacing: 0cm; mso-padding-alt: 0cm 0cm 0cm 0cm;&quot; Table&quot; border=&quot;0&quot; cellSpacing=&quot;0&quot; cellPadding=&quot;0&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
 &lt;/font&gt;&lt;tbody&gt;&lt;tr style=&quot;mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;td style=&quot;padding: 0cm; border: rgb(0, 0, 0); background-color: transparent;&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;table style=&quot;width: 116.6pt; mso-cellspacing: .7pt; mso-padding-alt: 0cm 0cm 0cm 0cm; mso-table-lspace: 2.25pt; mso-table-rspace: 2.25pt; mso-table-anchor-vertical: paragraph; mso-table-anchor-horizontal: column; mso-table-left: right; mso-table-top: middle;&quot; Table&quot; border=&quot;0&quot; cellSpacing=&quot;1&quot; cellPadding=&quot;0&quot; width=&quot;155&quot; align=&quot;right&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
   &lt;/font&gt;&lt;tbody&gt;&lt;tr style=&quot;mso-yfti-irow: 0; mso-yfti-firstrow: yes;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
    &lt;/font&gt;&lt;td style=&quot;padding: 3.75pt; border: rgb(0, 0, 0); background-color: transparent;&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
    &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;font-size: 9pt;&quot; &gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=186&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;span style=&quot;text-decoration: none; text-underline: none;&quot;&gt;&lt;v:shape style=&quot;width: 162.75pt; height: 108pt;&quot; id=&quot;_x0000_i1030&quot; type=&quot;#_x0000_t75&quot; alt=&quot;http://assets.fiercemarkets.com/public/lapband.jpg&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;&lt;/font&gt;&lt;/v:shape&gt;&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;/span&gt;&lt;/p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
    &lt;/font&gt;&lt;/td&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
   &lt;/font&gt;&lt;/tr&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
   &lt;/font&gt;&lt;tr style=&quot;mso-yfti-irow: 1; mso-yfti-lastrow: yes;&quot;&gt;&lt;font face=&quot;Times New Roman&quot;&gt;
    &lt;/font&gt;&lt;td style=&quot;padding: 3.75pt; border: rgb(0, 0, 0); background-color: transparent;&quot;&gt;&lt;font size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
    &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;i&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;Allergan is looking to
    unload its obesity device business, which includes the once-popular
    Lap-Band--courtesy of Allergan&lt;/span&gt;&lt;/i&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;/span&gt;&lt;/p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
    &lt;/font&gt;&lt;/td&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
   &lt;/font&gt;&lt;/tr&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;font color=&quot;#000000&quot;&gt;Now that it's done
  &quot;exploring strategic options,&quot; Allergan (&lt;/font&gt;&lt;a name=&quot;fiercemedicaldevices_com__nUiB0CRbrwZxzJ&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=18&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;$AGN&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;font color=&quot;#000000&quot;&gt;) is all-in &lt;/font&gt;&lt;span style=&quot;color: red;&quot;&gt;on plans to sell
  off its obesity-intervention business, expecting to ink a deal by June.&lt;br&gt;
  &lt;/span&gt;&lt;font color=&quot;#000000&quot;&gt;The unit, which includes Allergan's &lt;/font&gt;&lt;a name=&quot;fiercemedicaldevices_com__kStSaIv3sdHWeo&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=20&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Lab-Band&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;font color=&quot;#000000&quot;&gt; device and Orbera intragastric balloon system,
  has faced a slump in demand over the past year. In 2012, revenue plummeted
  21.5% to $159.5 million amid concerns over Lap-Band's safety and a failed bid
  to get the device indicated for teens.&lt;br&gt;
  So, who wants to buy it? Last month, CEO David Pyott said the company had
  attracted interest from at least one private equity outfit, but Allergan is
  about four years removed from Lap-Band's heyday and is unlikely to find a
  blockbuster deal. As &lt;i&gt;Bloomberg&lt;/i&gt; notes, the obesity unit peaked in 2009
  with $296 million in annual revenue, &lt;/font&gt;&lt;span style=&quot;color: red;&quot;&gt;but an onslaught
  of lawsuits and research questioning Lap-Band's effectiveness have whittled
  away at profits ever since.&lt;br&gt;
  &lt;/span&gt;&lt;font color=&quot;#000000&quot;&gt;In the meantime, Allergan is planning to report its obesity revenues
  as a discontinued operation from here on out. But the company believes it can
  keep growing even with Lap-Band in the rearview, projecting obesity-free 2013
  revenue of up to $6.2 billion, about 8.9% over 2012. Driving that growth are
  big sales expectations for the eye drugs Alphagan and Restasis, plus another
  giant year for Botox, which Allergan projects to bring in up to $2 billion on
  its own.&lt;br&gt;
  - read Allergan's &lt;/font&gt;&lt;a name=&quot;fiercemedicaldevices_com__YNfA4eJO0j5ygd&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=52&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;statement&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;br&gt;&lt;font color=&quot;#000000&quot;&gt;
  - check out its full &lt;/font&gt;&lt;a name=&quot;files_shareholder_com_dow_2TVKVzyK3n6PSG&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=63&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Q4 results&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;font color=&quot;#000000&quot;&gt; (pdf)&lt;br&gt;
  - here's the &lt;i&gt;Bloomberg&lt;/i&gt; &lt;/font&gt;&lt;a name=&quot;bloomberg_com_news_2013_0_knT8e8mxZaD9iA&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=128&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;story&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;br&gt;&lt;font color=&quot;#000000&quot;&gt;
  &lt;b&gt;Related Articles:&lt;/b&gt;&lt;br&gt;
  &lt;/font&gt;&lt;a name=&quot;fiercemedicaldevices_com__O4iLefMBkRrAx7&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=203&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Allergan mulls sale of its anti-obesity device business&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;br&gt;&lt;font color=&quot;#000000&quot;&gt;
  &lt;/font&gt;&lt;a name=&quot;fiercemedicaldevices_com__jBqGqcWyIiodoV&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=221&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Allergan abandons pursuit of U.S teen market for Lap-Band
  obesity device&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;br&gt;&lt;font color=&quot;#000000&quot;&gt;
  &lt;/font&gt;&lt;a name=&quot;fiercemedicaldevices_com__PuTkKYd5DxiA9H&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=158&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Allergan subpoenaed over Lap-Band obesity device&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;br&gt;&lt;font color=&quot;#000000&quot;&gt;
  &lt;/font&gt;&lt;a name=&quot;fiercepharma_com_story_bo_yMYUl7hDwqxUok&quot;&gt;&lt;/a&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=173&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Botox for migraine provides added boost to Allergan&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;font color=&quot;#000000&quot;&gt;Read more about: &lt;/font&gt;&lt;a href=&quot;http://links.mkt1985.com/ctt?kn=18&amp;ms=NDcxMDc5MgS2&amp;r=MTk5NjIxNDIzNDES1&amp;b=3&amp;j=MTQxNjY4ODE4S0&amp;mt=1&amp;rt=0&quot; target=&quot;_blank&quot;&gt;&lt;u&gt;&lt;font color=&quot;#0066cc&quot;&gt;Allergan&lt;/font&gt;&lt;/u&gt;&lt;/a&gt;&lt;br&gt;&lt;font color=&quot;#000000&quot;&gt;
&amp;nbsp; &lt;/font&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style=&quot;margin: 0cm 0cm 0pt; text-align: left; word-break: keep-all; mso-pagination: widow-orphan;&quot;  align=&quot;left&quot;&gt;&lt;span style=&quot;font-family: Georgia; font-size: 12pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림;&quot; &gt;&lt;font color=&quot;#000000&quot;&gt;&lt;/font&gt;&lt;/span&gt;&amp;nbsp;&lt;/p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;
  &lt;/font&gt;&lt;/td&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
 &lt;/font&gt;&lt;/tr&gt;&lt;font color=&quot;#000000&quot; face=&quot;Times New Roman&quot;&gt;
&lt;/font&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;font color=&quot;#000000&quot; size=&quot;3&quot; face=&quot;Times New Roman&quot;&gt;

&lt;/font&gt;&lt;/p&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>Allergan plans to sell off Lpaband Biz by midyear</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/248"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.248]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2013-02-08T14:54:43Z]]></updated>
		    <published><![CDATA[2013-02-08T14:54:43Z]]></published>
		    <content type="html">
		    	&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;font color=&quot;#ff0000&quot;&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;&lt;/span&gt;&lt;/font&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;font color=&quot;#ff0000&quot;&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;앨거간사는 2013년 6월까지 랩밴드 사업부를 매각하기로 결정&amp;nbsp;하였습니다.,&lt;/span&gt;&lt;/font&gt;&lt;/p&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;&lt;p&gt;&lt;font color=&quot;#ff0000&quot;&gt;&lt;/font&gt;&amp;nbsp;&lt;/p&gt;&lt;/span&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;&lt;p&gt;&lt;font color=&quot;#ff0000&quot;&gt;&lt;/font&gt;&amp;nbsp;&lt;/p&gt;&lt;/span&gt;&lt;p&gt;&lt;A href=&quot;http://www.bloomberg.com/news/2013-02-05/allergan-seeks-to-sell-lap-band-and-obesity-unit-by-june.html&quot; target=&quot;_blank&quot;&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;&lt;font color=&quot;#ff0000&quot;&gt;http://www.bloomberg.com/news/2013-02-05/allergan-seeks-to-sell-lap-band-and-obesity-unit-by-june.html&lt;/font&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style=&quot;font-size: 12pt;&quot;&gt;&lt;font color=&quot;#ff0000&quot;&gt;&lt;/font&gt;&lt;/span&gt;&lt;/p&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>위밴드 이제는 미드밴드입니다.</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/246"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.246]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2013-01-09T01:30:56Z]]></updated>
		    <published><![CDATA[2013-01-09T01:30:56Z]]></published>
		    <content type="html">
		    	&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;이제 2013년의 새해가 밝았습니다. 여러분 새해 복 많이 받으시고 건강하세요!!!&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;금년은 저희 미드밴드의 실질적인 대한민국 상륙의 원년이라고 할 수있겠습니다. 그동안 저희&amp;nbsp;미드밴드를 사용하시고 그 탁월한 효과를 몸소 체험하신 의사 선생님들의 관심과 사랑에 대하여 진심으로 깊은 감사의 말씀을&amp;nbsp;드립니다.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;위밴드&amp;nbsp;수술을 생각하시는&amp;nbsp;모든 분들을 위하여 미드밴드 사용병원을 알려드리고자 합니다. 원장님/교수님 말씀 잘 들으시고 현명한 판단을 하시기를 바라겠습니다.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;1. 예다인 외과&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;권수인 원장님&lt;/p&gt;&lt;p&gt;2. 365 mc&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 조민영 원장님&amp;nbsp;&lt;/p&gt;&lt;p&gt;3. 서울스카이 병원&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&amp;nbsp; 강세훈 대표원장님&lt;/p&gt;&lt;p&gt;4. 강남 차병원&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;한상문 교수님&lt;/p&gt;&lt;p&gt;5. 서울 한남동 순천향병원&amp;nbsp; 김용진 교수님&lt;/p&gt;&lt;p&gt;6. 중앙대학교 병원&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 박중민 교수님&lt;/p&gt;&lt;p&gt;7. 가천의대 인천 길병원&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 김성민 교수님&lt;/p&gt;&lt;p&gt;8. 대구 경대연합외과&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 이상호 원장님&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;이제 위밴드의 인식 전환이 필요한 시기입니다. 동일한 수준의 밴드수술을 쉽고 간단하게 할 수 있어야 하겠으며, 당연히 부작용도 적어야 하겠지요. 그 동안&amp;nbsp;시장을 독점하며 엄청난 가격으로 환자들의 주머니를 축낸 밴드 이제는 아니라고 보아야겠지요?&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;참고로 365mc의원은 금년 1월18일 교대역 인근으로 이전하며 15층 건물로써 대한민국 최고의 비만전문 클리닉&amp;nbsp;센터를&amp;nbsp;오픈합니다.&amp;nbsp;여러분들의 많은 관심과 사랑 부탁드립니다.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;감사합니다.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;한국 미드밴드 사업부&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>위밴드 미드밴드 수술 연구보고서</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/245"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.245]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2013-01-02T23:02:15Z]]></updated>
		    <published><![CDATA[2013-01-02T23:02:15Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=center&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 14pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;Prospective, Multicenter, 3-Year Trial of Laparoscopic&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=center&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 14pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;Adjustable Gastric Banding with the MIDBAND&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 14pt; mso-bidi-font-family: 'AdvTTb8864ccf.B+21'; mso-font-kerning: 0pt&quot; &gt;™&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&lt;FONT size=2&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;FONT size=2&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Christian Gouillat &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Angélique Denis &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Perrine Badol-Van Straaten &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Vincent Frering &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;FONT size=2&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Jacques Tussiot &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Pierre Campan &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Gérard Aulagnier &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Valeria Costamagna &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;FONT size=2&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Jean-françois Ain &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Robert Portet &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Michel Roche &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Celestin Esso &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;FONT size=2&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Jean-Marie Molasoko &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Yves Claret &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Jacques Desplantez &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Sébastien Le Page &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;FONT size=2&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Marie Cécile Blanchet &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Maud Robert &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvP0005; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;&amp; &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt; ; mso-ansi-language: FR&quot; lang=FR&gt;Isabelle Jaisson-Hot&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;FONT size=2&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvPi3; mso-font-kerning: 0pt; &quot; &gt;# &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; ; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Springer Science+Business Media, LLC 2011&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;Abstract&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTT50a2f13e.I'; mso-font-kerning: 0pt&quot; &gt;Background &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Although laparoscopic adjustable gastric banding (LAGB) is a popular metabolic/bariatric procedure, few prospective studies have assessed its outcomes. &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;This study aimed to prospectively assess LAGB safety and effectiveness outcomes using the MIDBAND &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231+21; mso-font-kerning: 0pt&quot; &gt;™ &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;(MID, Dardilly, France).&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTT50a2f13e.I'; mso-font-kerning: 0pt&quot; &gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTT50a2f13e.I'; mso-font-kerning: 0pt&quot; &gt;Methods &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Between May 2005 and September 2006, 262 morbidly obese patients underwent primary gastric banding with pars flaccida technique in 13 French medical centers.&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=center&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=center&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;Table 2 &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Complications – Midband&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Complication Number (%)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Band-related 12 (4.9)a&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: red; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Slippage 5 (2.0) -&amp;gt; 미끄러짐&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Intolerance 5 (2.0)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: red; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Erosion 1 (0.4) -&amp;gt; 위 미란&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Malfunction 1 (0.4)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Port-related 8 (3.3)&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;b&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Port twist 6 (2.5)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Pain at port site 2 (0.8)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Non-device-related 6 (2.5)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Pulmonary embolism 1 (0.4)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Deep venous thrombosis 1 (0.4)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Pulmonary infection 1 (0.4)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Port site hernia 2 (0.8)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Surgical site problem 1 (0.4)&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;c&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: red; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Total &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: red; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTT50a2f13e.I'; mso-font-kerning: 0pt&quot; &gt;N&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: red; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;=242 (20 patients with incomplete data)&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;a Reoperation including band removal&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;b &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Port revision under local anesthetic&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; WORD-BREAK: keep-all; mso-layout-grid-align: none&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: 'AdvTTb8864ccf.B'; mso-font-kerning: 0pt&quot; &gt;c &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;Reoperation for suture needle left in the surgical site&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0cm 0cm 0pt&quot; &gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: #131413; FONT-SIZE: 12pt; mso-bidi-font-family: AdvTT3713a231; mso-font-kerning: 0pt; mso-fareast-font-family: AdvTT3713a231&quot; &gt;OBES SURG&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt&quot; &gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title> 위밴드 바로 알고 선택하시기 바랍니다.</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/244"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.244]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2013-01-02T22:44:05Z]]></updated>
		    <published><![CDATA[2013-01-02T22:44:05Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;금일&amp;nbsp;인터넷에서 우연히 위밴드 선택이라는 글을 보았습니다.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;미국 FDA 정품 랩밴드를 광고하며...&amp;nbsp;본 글은 2012년2월 어느 소설가(?)에 의해 작성되었더군요.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;&quot; 현재 국내에서 사용되는 밴드를그림에 따라 비교하면서..&amp;nbsp; 필링을 반복하며 밴드의 내경이 둥굴게유지되지 &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;않는 것을 강조하면서...&quot;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;오류 1 :&amp;nbsp;미드밴드는 2012년 8월 한국 식약청 허가를 받았습니다. 그럼&amp;nbsp; 2012년 2월에 글쓴이가 밀수하여 시술하였나?&amp;nbsp;처벌받아야 되겠죠. 전화번호도 있던데.&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;어떻게&amp;nbsp;수입허가도 받지않고 사용도 안되는 밴드를 갖고 험담을 할까요? &lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;오류 2 : 미드밴드는 메뉴얼에 분명히 설명을 담고 있습니다.&amp;nbsp;Maximum 필링은 7cc라고.&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;미드밴드는 필링을 하지않고도 체중 감소가 가능한 밴드입니다. 그러나, 수술 후 일정 기간이 지나면(4 -8주후)환자의 상태를 보고 의사의 판단에 따라 필링을 하는것입니다. &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;즉, 7cc 이상 하는것은 특이한 경우이겠지요. 그러므로, 14cc까지 주입하여 형태가 변하는 것은 일어나지도 않는 경우를 가정한 것입니다. 글쓴이가 의사는 아니라고 느껴지는 부분입니다.&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;3. 오류 3 : 미드밴드는 위벽을 꿰매지 않아도 부작용이 타 밴드보다 현처히 낮다는 보고서가 많이 있습니다.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;즉, 밴드 채우고 필링 왕창하고 또 미끌어질까 두려워 위와 위를 꼬매고 있으니 수술시간은 얼마나 많이 걸리겠습니까???&amp;nbsp; &lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;&amp;nbsp;꼬매고 빡필해서 위미란(밴드가 위를 파고 드는 현상)이 발생하면 또 재수술하느라고 정신없고 이건 도대체 무슨 짓인지. 환자를 두번 세번 죽이는 일이지요. 꼬매는 것은 밴드가 흘러내려서 하는 것이랍니다. 미드밴드는 전혀 이러한 수술을 하지않아도 미끄러짐 현상이 2-3%에 불과합니다.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;그러므로, 미드밴드는 수술시간이 20분 내외인 반면에 타밴드는 40분에서 1시간 정도 걸리는 것입니다.&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;여러분, 위밴드 선택?&amp;nbsp; 정말 잘 알고 하시기 바랍니다. 타 밴드 험담하는 꼴은 이제 그만하시길 바랍니다.&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;한국 미드밴드 사업부&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID MIDBAND Appreciation Letter to Our Clients</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/243"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.243]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-12-19T14:46:25Z]]></updated>
		    <published><![CDATA[2012-12-19T14:46:25Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: black; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;Dear All Doctors, &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; COLOR: black; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;Thank you very much for your time, interest, and support in using MID Band for your patients this year. We highly appreciate your trust in us. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#0055ff&gt;Apparently there have been some concerns regarding a false perception amongst patients and practitioners that MID Band would be a cheap and inferior band. This could not be further from the truth.&lt;BR style=&quot;mso-special-character: line-break&quot;&gt;&lt;BR style=&quot;mso-special-character: line-break&quot;&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;We can only vouch for the excellent quality and performance of MID Band, and above all its added safety to patients, and efficient simplicity to surgeons. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;We have shared with you international data and results using MID Band, from some of the best (and busiest) bariatric centers in the world.&lt;BR&gt;&lt;SPAN style=&quot;mso-spacerun: yes&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;These repeatedly and typically show EWL of 60-85%, in 85-90% of patients, with slippage rates of 3% or less, over 5+ years with little loss to follow-up, and revision surgery rates of less than 5%. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;There results have led to an increasing number of surgeons globally proactively asking to MID Band. They are realizing that MID Band is a high quality European designed and manufactured product and very convenient, simple and safe to perform. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;&lt;FONT color=#0055ff&gt;It is by now the 2&lt;SUP&gt;nd&lt;/SUP&gt; most used gastric band in Europe, is sold in over 50 countries worldwide, with strong market shares in Australia, Canada, and Brazil. &lt;/FONT&gt;The only reason it is not used in the USA is the very high cost and very long time of registration. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#0055ff&gt;MID Band is priced at the same level to its major competitors in all of the above markets. In Asia and Korea we have responded to repeated requests from bariatric surgeons to offer a high quality product at a cheaper price. We are doing our best to meet the needs of you and your patients in this regard. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 6pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: .5&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;FONT color=#000000&gt;We are entering markets where our competitors are well established. We therefore have to offer a better value proposition to both you and your patients in order to compete. It is also important we have transparent and ethical business practices. For this reason we introduced ourselves and MID Band to each Asian market with a clear pricing policy. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 10pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;BR&gt;&lt;FONT color=#000000&gt;We will continue to offer our support to you and your patients throughout 2013 and beyond.&lt;BR&gt;&lt;FONT color=#0055ff&gt;We believe in the quality, value for money, and advantages of MID Band over our competitors. &lt;/FONT&gt;There is also no question of our focus and commitment to you and your patients as we regard bariatrics as a very important clinical need. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 10pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;BR&gt;&lt;FONT color=#ff0000&gt;Thank you once again for your interest and support for MID Band in 2012.&lt;BR&gt;Myself, Alex, and Teddy offer our best wishes to you and your family over Christmas and New Year. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 10pt; MARGIN: 0cm 0cm 0pt; BACKGROUND: white; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot;  align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-font-kerning: 0pt; mso-fareast-font-family: 굴림&quot; &gt;&lt;BR&gt;&lt;FONT color=#000000&gt;We look forward to seeing you again soon in 2013. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style=&quot;FONT-FAMILY: Georgia; FONT-SIZE: 12pt; mso-bidi-font-family: Arial; mso-fareast-font-family: 굴림; mso-ansi-language: EN-US; mso-fareast-language: KO; mso-bidi-language: AR-SA&quot; &gt;
&lt;P&gt;&lt;BR&gt;&lt;FONT color=#000000&gt;Kind Regards,&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000&gt;Vincent&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR style=&quot;mso-special-character: line-break&quot;&gt;&lt;BR style=&quot;mso-special-character: line-break&quot;&gt;&lt;/P&gt;&lt;/SPAN&gt;&lt;br&gt;&lt;br&gt;tag : &lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=MID MIDBAND GASTRIC BAND SURGERY&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;MID MIDBAND GASTRIC BAND SURGERY&lt;/a&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>좋은제품 제가격에 삽시다</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/242"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.242]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-12-18T20:51:32Z]]></updated>
		    <published><![CDATA[2012-12-18T20:51:32Z]]></published>
		    <content type="html">
		    	&lt;P style=&quot;TEXT-ALIGN: center&quot;&gt;&lt;img src=&quot;http://cfile230.uf.daum.net/image/2138763F50D05766163CCD&quot; class=&quot;tx-daum-image&quot; border=&quot;0&quot; hspace=&quot;1&quot; vspace=&quot;1&quot;/&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;p&gt;전세계 50 개국에서 사용하는 미드밴드 유럽 시장점유 2위 위밴드의  신세대 미드밴드&lt;/p&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID 국내에서 판매되고 있는 밴드의 수입가격</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/239"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.239]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-12-17T16:03:31Z]]></updated>
		    <published><![CDATA[2012-12-17T16:03:31Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;저는 미드밴드 한국 사무소 대표입니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;현재 미드밴드를 두고 여러가지 음해를 하는데 사실을 알려드립니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;랩밴드의 수입가격은 미드밴드의 수입가격과 거의 동일합니다. 저는 이미 2004년도부터 랩밴드를 호주의 이너메드사로부터 수입을 담당한 직원으로서 2010년도 앨러간으로 랩밴드 사업부가 매각되기 전까지 랩밴드 공급회사의 직원이었습니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;그런데 소비자가격은 왜 훨씬 비쌀까요?&amp;nbsp; 그동안 앨러간이 위벤드 시장을 독점하면서 폭리를 취한것이라고 밖에 볼 수 없는 것입니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;미드밴드는 한국시장의 후발주자로서 대기업 앨러간과 존슨 &amp; 존슨을 경쟁사로 두고있습니다.&lt;/P&gt;
&lt;P&gt;혁신적인 신제품이지만 새로운 시장에 진입하기 위해서는 관련 병의원 의사분들과 환자분들에게 신속히 &lt;/P&gt;
&lt;P&gt;알리기 위하여 상대적으로 저가 정첵을 공개적으로 시도한 것입니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;그런데, 싸구려 짝퉁 운운하는 악성 루머들이 돌아다니고&amp;nbsp;있습니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;여러분, &lt;/P&gt;
&lt;P&gt;랩밴드는 호주산, 스웨디시밴드는 본래 벨기에산입니다. 미드밴드는 프랑스입니다.&lt;/P&gt;
&lt;P&gt;식약청의 허가를 받은 당당한 위밴드입니다. 전세계 시장에서 전혀 손색이 없는 품질과 안전성 그리고, 수술의 편리성까지 갖춘 미드밴드가 가격도 합리적이라면 여러분은 무엇을 선택하시겠습니까?&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;랩밴드는 수술도중 미국에서 여러번 사망사고가 발생하였습니다. 그리고, 시장 점유율이 날로 감소하여 &lt;/P&gt;
&lt;P&gt;현재는 삼자 매각을 준비하고 있습니다. 2010년 2월 및 2012년 10월 뉴욕타임즈 발표&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;여러분들의 현명한 선택이 여려분들의 건강과 경제적 부담을 훨씬 줄여줄것입니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;감사합니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;한국 미드밴드 사업부&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID MIDBAND 수술 동영상</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/238"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.238]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-12-17T15:39:10Z]]></updated>
		    <published><![CDATA[2012-12-17T15:39:10Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;img class=&quot;txc-movie&quot; src=&quot;http://i1.daumcdn.net/svc/image/U03/tvpot_thumb/vcba3o5VYS728Y5QiQKG7iK/thumb.png.edit&quot; moviekey=&quot;vcba3o5VYS728Y5QiQKG7iK&quot; type=&quot;vi&quot;/&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-SIZE: 18pt&quot;&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 최고의 효과! 최소의 부작용 &lt;/SPAN&gt;&lt;/P&gt;&lt;br&gt;&lt;br&gt;tag : &lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=위밴드술&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;위밴드술&lt;/a&gt;,&amp;nbsp;&lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=위밴드 효과&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;위밴드 효과&lt;/a&gt;,&amp;nbsp;&lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=미드밴드의 장점&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;미드밴드의 장점&lt;/a&gt;,&amp;nbsp;&lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=세계가 인정한 최고의 밴드 미드밴드&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;세계가 인정한 최고의 밴드 미드밴드&lt;/a&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>건강</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/237"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.237]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-12-16T19:35:06Z]]></updated>
		    <published><![CDATA[2012-12-16T19:35:06Z]]></published>
		    <content type="html">
		    	&lt;p&gt;★육류고기의의 위험성(펌)&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;왜 육류고기를 더 많이 먹고 비만이 많은 미국, 호주 서양 사람들은 중풍 환자가 거의 없을까요? &lt;/p&gt;
&lt;p&gt;왜 대한민국은 40대가 넘으면 심지어 10대, 20대도 뇌졸중, 중풍으로 고생하고 목숨을 잃고 있을까요? 왜 한국에만 유독 많은 중풍 환자가 있을까요?&lt;/p&gt;
&lt;p&gt;이 문제에 대하여 외국 식습관을 비교 오랜 세월동안 연구를 했습니다.&lt;/p&gt;
&lt;p&gt;흔히들 짜게 먹는 것이 원인이라지만 그 보다 더한 것이 있답니다. &lt;/p&gt;
&lt;p&gt;사실 독일 같은 유럽 경우 음식을 보면 우리보다 더 짜게 먹기도 합니다.&lt;/p&gt;
&lt;p&gt;음식을 짜게 먹어서 중풍이나 뇌졸중이 빈번한것 보다 외국에서는 심혈관 질환때문에 버리는 쓰레기 삼겹살 그리고 곱창전골을 즐겨먹는 전통적인 한국의 식습관이 가장 큰 이유였습니다.&lt;/p&gt;
&lt;p&gt;1.서양 사람들은 돼지고기 소고기를 먹을때 비계 기름기를 먹지 않습니다. 그리고 소, 돼지, 양고기 내장 곱창은 더우기 먹지 않고 쓰레기로 버립니다. &lt;/p&gt;
&lt;p&gt;예외적으로 간은 먹기도 합니다.&lt;/p&gt;
&lt;p&gt;2.그러나 우리나라는 전통적으로 이 2가지 음식을 많이 즐겨 먹습니다. &lt;/p&gt;
&lt;p&gt;이 때문에 칠레, 유럽에서는 자기들은 먹지 않고 버리는 쓰레기 삼겹살, 곱창을 우리나라에 수출하고 있습니다. &lt;/p&gt;
&lt;p&gt;이 얼마나 웃기는 코메디 같은 이야기 아닙니까? &lt;/p&gt;
&lt;p&gt;중국도 돼지 고기를 많이 먹지만 비계 부분을 제거후 먹습니다.&lt;/p&gt;
&lt;p&gt;3.아마 전통적으로 삼겹살과 곱창전골을 이렇게 즐겨 많이 먹는 나라는 대한민국뿐이기도 합니다. &lt;/p&gt;
&lt;p&gt;그래서 대부분 우리 선조 조상들은 중풍으로 많이 돌아가셨고, 지금도 한국에는 남녀노소 많은 사람들이 심혈관 질병, 중풍, 뇌경색으로 고생하고 평생 불구로 고생하고 사망하고 있습니다. &lt;/p&gt;
&lt;p&gt;한국에서는 길거리에는 중풍이 걸려서 절뚝 절뚝하며 불구된 사람을 아주 가끔 목격되지만 외국에서는 이런 중풍 환자가 일체 볼 수가 없습니다.&lt;/p&gt;
&lt;p&gt;4.그리고 더 웃기는 것은 TV의 맛자랑 프로그램에는 항상 삼겹살, 곱창전골 요리하는 식당을 단골 메뉴로 시도 때도 없이 소개하고 있어 웃기는 비극이 일어나고 있습니다. &lt;/p&gt;
&lt;p&gt;이것이 현실입니다. &lt;/p&gt;
&lt;p&gt;하루빨리 우리 식습관을 시급&lt;/p&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID MIDBAND 위밴드 수술의 새 역사 - 미드밴드의 우수성</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/236"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.236]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-12-14T18:38:37Z]]></updated>
		    <published><![CDATA[2012-12-14T18:38:37Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: center&quot;&gt;&lt;STRONG&gt;&lt;FONT color=#ff0000&gt;&lt;SPAN style=&quot;FONT-SIZE: 14pt&quot;&gt;New Generation of Innovative Gastric Band In the World !!&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;미드밴드는 프랑스&lt;SPAN&gt; Medical Innovative Developpment(MID)&lt;/SPAN&gt;회사에서 생산하는 혁신적인 조절형 위밴드입니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;낮은 압력의 실리콘 밴드로써 본 제품은 탁월한 수술결과와 함께 지난&lt;SPAN&gt; 12&lt;/SPAN&gt;년간 전세계적으로 사용되고 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;미드밴드는 유럽시장에서&lt;SPAN&gt; 2&lt;/SPAN&gt;번째의 시장점유율을 나타내고 있으며 전세계 약&lt;SPAN&gt; 50&lt;/SPAN&gt;개국에서 판매되고 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;초과 체중의&lt;SPAN&gt; 60%&lt;/SPAN&gt;이상의 감량효과가 있는 반면에 미끄러짐이나 위를 파고드는 미란 현상은&lt;SPAN&gt; 2-3%&lt;/SPAN&gt;에 불과합니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;이는 현재 시장에 나와있는 다른 밴드보다 훨씬 우수한 수술결과를 의미합니다&lt;SPAN&gt;.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;FONT-FAMILY: 굴림; COLOR: #333333; FONT-SIZE: 9pt; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;미드밴드는 부드럽고 표면이 넓은 디자인으로 되어있어서 위의 구조에 아주 쉽고 자연스럽게 고정시킬 수 있는 것입니다&lt;SPAN&gt;. &lt;/SPAN&gt;이는 벨트와 같이 작은 주머니 위에 앉히는 것과 같으며 위를 파고드는 현상이 현저히 낮습니다&lt;SPAN&gt;. &lt;/SPAN&gt;이에 반하여&lt;SPAN&gt;, &lt;/SPAN&gt;타 밴드는 링 모양의 밴드 구조자체가 딱딱한 것으로 부자연스럽고 수술적응도 떨어질 뿐만 아니라 위를 파고드는 현상이 아주 놓습니다&lt;SPAN&gt;. &lt;/SPAN&gt;또한&lt;SPAN&gt;, &lt;/SPAN&gt;종종 위 상부를 목 조르는 듯한 모습을 보이고 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 11pt; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: 1.0&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;미드밴드는 독특한 디자인으로 설계되어있어서 타 밴드처럼 수술 시 밴드가 미끄러지지 않도록 위 상부와 하부를 묶어서 감쌀 필요가 없는 전세계에서 유일한 밴드입니다&lt;SPAN&gt;. &lt;/SPAN&gt;실제로&lt;SPAN&gt; 5,000&lt;/SPAN&gt;건 이상 위를 꿰매지 않고 수술을 시행하였음에도 탁월한 수술결과를 보이며 밴드의 미끄러짐 현상은 단&lt;SPAN&gt; 2%&lt;/SPAN&gt;에 불과하였습니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 11pt; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: 1.0&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;다른 밴드들은 아직도 위를 꿰매는 수술&lt;SPAN&gt;(Stitching)&lt;/SPAN&gt;을 하고 있는데&lt;SPAN&gt;, &lt;/SPAN&gt;이는 수술시간도 많이 걸릴 뿐만 아니라 위를 파고드는 현상을 증가시켜 더욱 많은 부작용이 일어날 수 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;반면에&lt;SPAN&gt; Non-Stitching &lt;/SPAN&gt;미드밴드는 수술시간이 짧고 쉬우며 간단합니다&lt;SPAN&gt;. &lt;/SPAN&gt;간혹 미끄러짐 현상이 발생되어도 감싼 위를 풀면서 생길 수 있는 위험성도 없고 복잡한 복원수술도 할 필요가 없으므로 쉽고 빠르게 제거할 수 있습니다&lt;SPAN&gt;.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 11pt; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: 1.0&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 11pt; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: 1.0&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;현재 세계적으로 선두그룹의 비만대사수술 외과의사분들이 미드밴드를 사용하고 있으며&lt;SPAN&gt;, &lt;/SPAN&gt;더욱더 많은 의사 분들이 적극적으로 앞장서서 미드밴드를 사용하도록 요구하고 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;그 분들은 미드밴드가 가장 편리하고 간단하며 안전한 위밴드라는 것을 실감하고 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; TEXT-INDENT: 11pt; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan; mso-char-indent-count: 1.0&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;프랑스 미드사는 전세계에 가장 우수하면서도 앞서가는 비만대사수술관련 의료기기를 공급하는데 헌신적인 노력을 하고 기울이고 있으며&lt;SPAN&gt;, &lt;/SPAN&gt;정도 경영을 바탕으로 자연스럽게 성장하고 있는 회사입니다&lt;SPAN&gt;.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;미드사는 꾸준히 지속적으로 미드밴드의 품질향상을 위한 연구를 하고 있으며 전세계에서 최고의 품질과 효능을 자랑하는 위밴드로서 확실한 자리매김을 하고 있습니다&lt;SPAN&gt;. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;본 제품이나 혹은 복강경수술로 시행하는 조절형 위밴드에 관하여 더 자세한 정보가 필요하시면 제조회사의 홈페이지 &lt;SPAN&gt;&lt;A href=&quot;http://www.midband.fr/&quot; target=_blank&gt;&lt;U&gt;&lt;FONT color=#0000ff&gt;www.midband.fr&lt;/FONT&gt;&lt;/U&gt;&lt;/A&gt;&lt;/SPAN&gt;을 참조하시기 바랍니다&lt;SPAN&gt;.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;감사합니다&lt;SPAN&gt;.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left; MARGIN: 0cm 0cm 0pt; TEXT-AUTOSPACE: ideograph-numeric; WORD-BREAK: keep-all; mso-pagination: widow-orphan&quot; align=left&gt;&lt;SPAN style=&quot;COLOR: #6600ff; FONT-SIZE: 11pt; mso-hansi-font-family: 바탕; mso-bidi-font-family: 굴림; mso-font-kerning: 0pt&quot;&gt;한국 미드밴드 사업부&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;MARGIN: 0cm 0cm 0pt&quot;&gt;&lt;SPAN&gt;&lt;FONT color=#000000 size=2&gt;&amp;nbsp;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;MID Band is a new innovative gastric band produced by the French company “MID”. MID Band has been used for the past 12 years all over the world, with excellent results. &lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&amp;nbsp; 
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;It is the 2&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&lt;SUP style=&quot;FONT-FAMILY: null&quot;&gt;nd&lt;/SUP&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt; most used band in &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&lt;XPLACE xmlns:w=&quot;urn:x-prefix:w&quot; w:st=&quot;on&quot;&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;Europe&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&lt;/XPLACE&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt; and is sold in over 50 countries worldwide. The reported weight loss results are in excess of 60% while complication rates (slippage &amp; erosion) are only 2-3%. These results are better than with any other gastric band in the world. &lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&amp;nbsp;MID Band’s soft and broad design makes it accommodate very easily and naturally to the anatomy of the stomach. &lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;It sits around the pouch like a belt, thereby making it less invasive than other bands which are harder in their composure and therefore less adaptive and less natural to the stomach, often strangling it in unhealthy fashion. &lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&amp;nbsp; 
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&amp;nbsp; MID Band’s unique design allows for it to not have to have a gastro-gastric wrap, meaning that surgeons don’t have to stitch the lower stomach to the upper stomach in order to fixate it. In fact, MID band is the only band in the world which has the clinical support of over 5,000 non-stitched bands, with excellent results and slippage rates of only 2%. &lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&amp;nbsp;All other gastric bands are still stitched which increases the time of the operation, makes it more invasive and adds potential complications. While not stitching MID Band, the operation is quick, easy and simple. &lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: red; FONT-SIZE: 10pt&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;&amp;nbsp;In case there is a slippage there is no complicated revision surgery required which would usually involve unwrapping the stitches and making the surgery dangerous and lengthy. In case of revision MID Band can be simply and quickly removed.&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; COLOR: red; FONT-SIZE: 12pt&quot;&gt;&lt;FONT style=&quot;FONT-FAMILY: null&quot; color=#000000&gt; &lt;/FONT&gt;&lt;/SPAN&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; COLOR: red; FONT-SIZE: 12pt&quot;&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT color=#000000 size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Dotum,돋움&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&amp;nbsp; &lt;FONT color=#000000&gt;Leading bariatric surgeons all over the world are using MID Band, and more and more surgeons have been proactively asking to use it. They are realizing that MID Band is the most convenient, simplest and safest gastric band in the world. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT color=#000000 size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&amp;nbsp; 
&lt;P style=&quot;mso-margin-top-alt: auto; mso-margin-bottom-alt: auto&quot;&gt;&lt;FONT color=#000000 size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Dotum,돋움&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&amp;nbsp; &lt;FONT color=#030066&gt;MID is a well managed and naturally grown company which is dedicated to supplying the best and leading bariatric devices in the world. They are constantly working on and improving MID Band, making sure it will maintain its status as the best band in the world. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; COLOR: red; FONT-SIZE: 12pt&quot;&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000 size=2 face=Arial&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Gulim,굴림&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Dotum,돋움&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕&quot;&gt;Thanks,&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;&lt;br&gt;&lt;br&gt;tag : &lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=살빼는 방법&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;살빼는 방법&lt;/a&gt;,&amp;nbsp;&lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=위밴드수술&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;위밴드수술&lt;/a&gt;,&amp;nbsp;&lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=위밴드&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;위밴드&lt;/a&gt;,&amp;nbsp;&lt;a href=&quot;/_blog/tagArticleList.do?blogid=0Plot&amp;tagName=고도비만수술&quot; rel=&quot;tag&quot; target=&quot;_blank&quot;&gt;고도비만수술&lt;/a&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID MIDBAND CLINICAL REPORTS 임상자료</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/234"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.234]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-11-06T11:31:08Z]]></updated>
		    <published><![CDATA[2012-11-06T11:31:08Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;비만대사 수술 전문의용 미드밴드 임상자료입니다. 많이 활용하시기 바랍니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href=&quot;http://cfile235.uf.daum.net/attach/133CFE34509875F829C7E7&quot; target=&quot;_blank&quot;&gt;&lt;img src=&quot;http://i1.daumcdn.net/icon/editor/p_pdf_s.gif?rv=1.0.1&quot;/&gt; Clinical Report Midband 2008.pdf&lt;/a&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href=&quot;http://cfile225.uf.daum.net/attach/0141AE33509876212123C7&quot; target=&quot;_blank&quot;&gt;&lt;img src=&quot;http://i1.daumcdn.net/icon/editor/p_pdf_s.gif?rv=1.0.1&quot;/&gt; Clinical Reports 2009-10.pdf&lt;/a&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>임상자료 2008 - 2010</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/232"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.232]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-11-05T14:57:35Z]]></updated>
		    <published><![CDATA[2012-11-05T14:57:35Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;비만대사 수술 전문의용 임상자료입니다. 많이 활용하시기 바랍니다.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;첨부파일 1. 임상자료 2008&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; 2. 임상자료 2009-2010&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID Excellent Results of MIDBAND with Least Complication</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/230"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.230]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-11-04T15:28:44Z]]></updated>
		    <published><![CDATA[2012-11-04T15:28:44Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; FONT-SIZE: 12pt&quot;&gt;The &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; COLOR: blue; FONT-SIZE: 12pt&quot;&gt;MIDBAND &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: null&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;is produced by MID of &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: null&quot;&gt;&lt;?XML:NAMESPACE PREFIX = ST1 /&gt;&lt;ST1:PLACE w:st=&quot;on&quot;&gt;Lyon, France.&lt;/ST1:PLACE&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial Narrow'; COLOR: #333366&quot;&gt;&lt;FONT color=#000000&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; FONT-SIZE: 12pt&quot;&gt;It is rapidly gaining popularity with a number of &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; FONT-SIZE: 12pt&quot;&gt;&lt;ST1:COUNTRY-REGION w:st=&quot;on&quot;&gt;&lt;ST1:PLACE w:st=&quot;on&quot;&gt;UK&lt;/ST1:PLACE&gt;&lt;/ST1:COUNTRY-REGION&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: null&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;, French and Mexican surgeons.&amp;nbsp; &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#000000&gt;&amp;nbsp;&lt;/FONT&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 11pt&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;&lt;FONT color=#000000&gt;Several thousands have been placed and &lt;/FONT&gt;&lt;FONT color=#ff0000&gt;the results appear to be promising-especially within the area of complications. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style=&quot;FONT-FAMILY: Batang,바탕; FONT-SIZE: 12pt&quot;&gt;밴드 선택 전에 고려할 사항들:&amp;nbsp;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 18pt&quot;&gt;&lt;FONT color=#333366&gt;&lt;FONT face=&quot;Arial Narrow&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;Whilst the experiences of other banded patients is important, it is essential that your choice of band should be made in consultation with your surgeon and following your own research of the available literature. The bands all have advantages and disadvantages.&lt;FONT color=#ff0000&gt; It is important that you find the best one for you.&lt;/FONT&gt;&lt;/SPAN&gt;&lt;BR&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;Prior to leaving your home&amp;nbsp;for surgery, &lt;FONT color=#ff0000&gt;it is essential that you make provision for safe and effective follow up care upon your return. &lt;/FONT&gt;&lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-FAMILY: 'Arial Narrow'; COLOR: #333366; FONT-SIZE: 12pt&quot;&gt;&lt;FONT color=#ff0000&gt;This will reduce the risk of potential complications such as port damage, tube puncture and infection.&lt;/FONT&gt; A trained and experienced adjuster will be able to advise regarding &lt;FONT color=#ff0000&gt;the correct volume for you&lt;/FONT&gt;. Do not delegate this task to a nurse or doctor with &lt;STRONG&gt;no experience of band adjustment-it could be a very costly mistake and could increase the risk of serious complications such as erosion and slippage.&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 18pt&quot;&gt;&lt;STRONG&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; FONT-SIZE: 11pt&quot;&gt;The Midband:&lt;/SPAN&gt;&lt;/STRONG&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial; FONT-SIZE: 11pt&quot;&gt; This band is shorter than Lap band and Swedish Band, &lt;FONT color=#ff0000&gt;which makes it resistant to erosion and reduces the irritation to the gastric wall lining. &lt;/FONT&gt;The Midband can be easily detected with the help of X-rays, which makes the adjustment process easier. Just like the other bands mentioned above, this band can be tightened or loosened to control the quantity of grub the patient consumes.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: left&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 18pt&quot;&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
		    </content>
		    		</entry>
	    		<entry>
		    <title>MID What is the MIDBAND?</title>
			<link rel="alternate" type="text/html" href="http://blog.daum.net/teddy8412/229"/>
			<id><![CDATA[tag:blog.daum.net,2013:teddy8412.229]]></id>
		    <author>
			    <name><![CDATA[Europos Korea]]></name>
		    </author>
		    <updated><![CDATA[2012-11-04T12:45:44Z]]></updated>
		    <published><![CDATA[2012-11-04T12:45:44Z]]></published>
		    <content type="html">
		    	&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;미드밴드는 프랑스 리용의 닥터 페링박사가 스웨디쉬 밴드와 랩밴드 디자인의 폭넓은 경험을 바탕으로 1996년 개발한 신세대 혁신적인 위밴드입니다.&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify&quot;&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;미드밴드는 굉장히 부드럽고 구부리기가 쉬워서 부착이 아주 용이하면서도 늘어나지 않으며, 타 밴드에 비해서 유일하게 밴드 이중 잠금장치가 되어있어서 신체적인 조건을 훨씬 능가하는 탄력성있으며 필링시 조이는 능력이 탁월합니다. &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify&quot;&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;TEXT-ALIGN: justify&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;미드밴드는 날카로운 모서리가 없으면서 표면이 매끄러워&amp;nbsp;심지어 마찰이 생기더라도 위벽을 손상하지않는 장점이 있습니다. &lt;/SPAN&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;또한, 엑스레이 불투과성 실리콘 재질이기 때문에 정확한 위치에 부착과 조절이 아주 쉽다.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style=&quot;WIDTH: 900px&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;The MIDBAND was designed with the advice and guidance of Dr. Vincent Frering after his extensive experience with other bands, such as the American Lapband (Inamed)and the Swedish Band (previously Obtech and now Johnson &amp; Johnson).&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;WIDTH: 900px&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;The MIDBAND is an adjustable peri-gastric belt, implantable by laparoscopy. It is indicated for surgical treatment of morbid obesity defined by an index of mass in excess of 40 kg/m2 (or 35 kg/m2 with co-morbidities).&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;WIDTH: 900px&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;The MIDBAND provides a very attractive alternative to conventional surgical methods which are more invasive and irreversible, requiring extended hospitalization.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;WIDTH: 900px&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;The MIDBAND is extremely flexible making it easy to fit. It is inextensible, and the unique double closure system ensures a fastening capacity far in excess of the physiological conditions required.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style=&quot;WIDTH: 900px&quot;&gt;&lt;SPAN style=&quot;FONT-FAMILY: Arial&quot;&gt;&lt;SPAN style=&quot;FONT-SIZE: 12pt&quot;&gt;The MIDBAND has no sharp edges or irregularities thereby preserving the gastric wall intact, even in event of rubbing. It is opaque to X rays, making it easy to locate and adjust.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;DIV align=center&gt;&lt;/DIV&gt;
		    </content>
		    		</entry>
	    	  	</feed>
